Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation

Cosio, 2008, Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes, Am J Transplant, 8, 593, 10.1111/j.1600-6143.2007.02101.x Wimmer, 2007, The Janus face of immunosuppression — de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich, Kidney Int, 71, 1271, 10.1038/sj.ki.5002154 Cormier, 2003, Diagnosis and treatment of prostate cancers in renal-transplant recipients, Transplantation, 75, 237, 10.1097/01.TP.0000041785.38998.6C Shand, 2016, Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies, Mol Clin Oncol, 5, 315, 10.3892/mco.2016.952 Stöckle, 2018, Low-risk prostate cancer prior to or after kidney transplantation, Eur Urol Focus, 4, 148, 10.1016/j.euf.2018.07.003 Vitiello, 2015, Utility of prostate cancer screening in kidney transplant candidates, J Am Soc Nephrol, 27, 2157, 10.1681/ASN.2014121182 Engels, 2011, Spectrum of cancer risk among US solid organ transplant recipients, JAMA, 306, 1891, 10.1001/jama.2011.1592 Boissier, 2018, The risk of tumour recurrence in patients undergoing renal transplantation for end-stage renal disease after previous treatment for a urological cancer: a systematic review, Eur Urol, 73, 94, 10.1016/j.eururo.2017.07.017 Liauw, 2020, Prostate cancer outcomes following solid-organ transplantation: a SEER-Medicare analysis, J Natl Cancer Inst, 112, 847, 10.1093/jnci/djz221 Cresp-Leiro, 2008, Malignancy after heart transplantation: incidence, prognosis and risk factors, Am J Transplant, 8, 1031, 10.1111/j.1600-6143.2008.02196.x